M
Maple
Online doctors, virtual health & prescriptions in Canada
About Maple
Maple is a Canadian-based startup operating in the healthcare sector, specifically in the telemedicine market. The company provides a virtual platform that allows patients to consult with Canadian-licensed doctors anytime, anywhere. This service is particularly beneficial for those who struggle to find a family doctor or need medical attention outside regular office hours.
Read full description
Maple's business model is centered on providing on-demand healthcare services 24/7. Patients can either book an appointment with a specialist or get immediate virtual care. The platform also offers access to specialty care, including mental health, dermatology, and pediatric primary care.
The company generates revenue by charging for the consultations. The cost varies depending on the type of consultation, with immediate virtual care being more expensive than scheduled appointments. The platform is highly rated by users, boasting over 800,000 five-star reviews, which indicates a high level of customer satisfaction and trust in the service.
Maple's services are not only convenient but also efficient. Patients have reported getting their prescriptions within minutes and being able to complete processes that would typically require a referral and a six-month wait in less than 72 hours. This efficiency, coupled with the convenience of accessing healthcare services from the comfort of home, positions Maple as a valuable player in the telemedicine market.
At a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Toronto, Canada
- Employees
- 241
- Open positions
- 11
- Dealroom signal
- 75.2/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Mental Health, Telemedicine, Tech for Patients, Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
- Investment activity
- 2 companies, latest Nov 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Sep 2020 | $55M | $220M | Shoppers Drug Mart | ↗ |
| SERIES AOther financing | Sep 2019 | $15M | $58M | Acton Capital | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Maple is 360K monthly website visits, up 0% over the last three months. Maple's team grew 0.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Beyond ADHDCanadaVirtual ADHD assessments, diagnosis, and personalized treatment
→
WelloToronto, CanadaA healthier workforce and workplace starts with Wello. 24/7 holistic care. Ask us how we can support your employees
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
MaRS Investment Accelerator Fund
Series A2 investors entered at this stage
Acton Capital
Shoppers Drug Mart
Other known investors2 additional known investors
- OVOnWave Ventures
Royal Bank of Canada
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Maple on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Maple’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.